Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.

[1]  A. Buist.  Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[2]  E. Russi,et al.  Improved quality of life after lung volume reduction surgery , 2002, European Respiratory Journal.

[3]  R. Dahl,et al.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[4]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[5]  A. Nissinen,et al.  Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study , 2001, Thorax.

[6]  F. Platt,et al.  Let Me See If I Have This Right : Words That Help Build Empathy , 2001, Annals of Internal Medicine.

[7]  C. Brambilla,et al.  Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study , 2001, The Lancet.

[8]  N. Ambrosino,et al.  Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. , 2001, Chest.

[9]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[10]  A. Cuvelier,et al.  Noninvasive ventilation and obstructive lung diseases. , 2001, The European respiratory journal.

[11]  D. Mahler,et al.  Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. , 2001, The European respiratory journal.

[12]  N. Zamel,et al.  Lung function 5 yr after lung volume reduction surgery for emphysema. , 2001, American journal of respiratory and critical care medicine.

[13]  J. Finnerty,et al.  The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. , 2001, Chest.

[14]  P. Poole,et al.  Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review , 2001, BMJ : British Medical Journal.

[15]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[16]  M. De Salvo,et al.  In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. , 2001, Chest.

[17]  D. Mccrory,et al.  Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.

[18]  V. Snow,et al.  Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.

[19]  D. Mccrory,et al.  Management of acute exacerbations of COPD: a summary and appraisal of published evidence. , 2001, Chest.

[20]  R. Zuwallack,et al.  Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease , 2001 .

[21]  S. Hurd,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[22]  M. Saetta,et al.  Pathogenesis and Pathology of COPD , 2001, Respiration.

[23]  N. Konietzko,et al.  Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease Inhibitor , 2001 .

[24]  M. Decramer,et al.  The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. , 2001, The European respiratory journal.

[25]  D. Brooks,et al.  Nutritional intervention in COPD: a systematic overview. , 2001, Chest.

[26]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[27]  Robert West,et al.  Smoking cessation guidelines for health professionals: an update , 2000, Thorax.

[28]  H. Schäfers,et al.  Lung volume reduction surgery versus conservative treatment in severe emphysema. , 2000, The European respiratory journal.

[29]  J. Lieberman.  Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. , 2000, Chest.

[30]  T. Mineo,et al.  Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. , 2000, The Annals of thoracic surgery.

[31]  J. Steurer,et al.  The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. , 2000, The European respiratory journal.

[32]  D. Hansell,et al.  Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.

[33]  M. Elliott,et al.  One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration , 2000, Thorax.

[34]  M. Niederman,et al.  The role of bacteria in exacerbations of COPD. A constructive view. , 2000, Chest.

[35]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[36]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[37]  W. Hop,et al.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.

[38]  M. Littner,et al.  Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[39]  J. V. van Noord,et al.  A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .

[40]  A. Buist,et al.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. , 2000, Chest.

[41]  N. Hill.  Noninvasive ventilation has been shown to be ineffective in stable COPD. , 2000, American journal of respiratory and critical care medicine.

[42]  A. Rossi.  Noninvasive ventilation has not been shown to be ineffective in stable COPD. , 2000, American journal of respiratory and critical care medicine.

[43]  P. O'Malley,et al.  Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency? , 2000 .

[44]  D. Brooks,et al.  Nutritional support for individuals with COPD: a meta-analysis. , 2000, Chest.

[45]  Barnes Pj.  Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. , 2000 .

[46]  D. Mahler.  How should health-related quality of life be assessed in patients with COPD? , 2000, Chest.

[47]  S. Hurd,et al.  The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.

[48]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[49]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[50]  G. Criner,et al.  Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[51]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[52]  E. Russi,et al.  Two years' outcome of lung volume reduction surgery in different morphologic emphysema types. , 1999, The Annals of thoracic surgery.

[53]  J. Vestbo,et al.  Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. , 1999, Respiratory medicine.

[54]  E. Russi,et al.  Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery. , 1999, The European respiratory journal.

[55]  L. Davies,et al.  Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease. , 1999, QJM : monthly journal of the Association of Physicians.

[56]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[57]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[58]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[59]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[60]  C. Westermann,et al.  Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[61]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[62]  Y. Lacasse,et al.  Overviews of respiratory rehabilitation in chronic obstructive pulmonary disease. , 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[63]  U Ackermann-Liebrich,et al.  Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. , 1999, American journal of respiratory and critical care medicine.

[64]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[65]  D. Mannino,et al.  Worldwide epidemiology of chronic obstructive pulmonary disease. , 1999, Current opinion in pulmonary medicine.

[66]  M. Moy,et al.  Health-related quality of life improves following pulmonary rehabilitation and lung volume reduction surgery. , 1999, Chest.

[67]  S. Campbell,et al.  For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. , 1999, Archives of internal medicine.

[68]  D. Postma,et al.  Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis , 1999, Thorax.

[69]  D. Brooks,et al.  The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. , 1998, Chest.

[70]  P. Paggiaro,et al.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.

[71]  W. Stalman,et al.  Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.

[72]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[73]  C. Pichard,et al.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.

[74]  Alison E. Ries.  Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.

[75]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[76]  N. Banik,et al.  Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. , 1997, The European respiratory journal.

[77]  D. Mannino,et al.  Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. , 1997, American journal of respiratory and critical care medicine.

[78]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[79]  R. Zuwallack,et al.  Body composition and health-related quality of life in patients with obstructive airways disease. , 1997, The European respiratory journal.

[80]  T. Sensky,et al.  Psychosocial predictors of long-term success of in-patient pulmonary rehabilitation of patients with COPD. , 1997, The European respiratory journal.

[81]  J. Stoller.  Clinical features and natural history of severe α1-antitrypsin deficiency , 1997 .

[82]  T. Rochat,et al.  Management 1997 of chronic obstructive pulmonary disease. Working Group of the Swiss Society of Pneumology. , 1997, Schweizerische medizinische Wochenschrift.

[83]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[84]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[85]  J. Heffner,et al.  Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.

[86]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[87]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[88]  Gordon H Guyatt,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.

[89]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[90]  S. Rennard,et al.  Clinical Investigations: COPDExtended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPD: A Retrospective Analysis of Data From Seven Clinical Trials , 1996 .

[91]  M. Decramer,et al.  Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[92]  E. Silverman,et al.  Risk factors for the development of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.

[93]  D. Postma,et al.  Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.

[94]  D. Maldonado,et al.  Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.

[95]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[96]  J. Henningfield.  Nicotine medications for smoking cessation. , 1995, The New England journal of medicine.

[97]  J. Deslauriers,et al.  Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.

[98]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[99]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[100]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[101]  M. Stewart.  Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[102]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.

[103]  P. Barnes,et al.  Theophylline and phosphodiesterase inhibitors. , 1995, The European respiratory journal.

[104]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[105]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[106]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[107]  B. Delclaux,et al.  Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. , 1994, The European respiratory journal.

[108]  D. Mant,et al.  Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.

[109]  O. Brändli,et al.  [High-caloric nutrition in chronic obstructive lung disease]. , 1994, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.

[110]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[111]  H Spiro,et al.  What is empathy and can it be taught? , 1992, Annals of internal medicine.

[112]  J. Fitting.  Nutritional support in chronic obstructive lung disease. , 1992, Thorax.

[113]  J. Samet,et al.  Epidemiologic approaches for assessing health risks from complex mixtures in indoor air. , 1991, Environmental health perspectives.

[114]  P. Howard,et al.  Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. , 1991, Thorax.

[115]  B. Burrows.  Epidemiologic evidence for different types of chronic airflow obstruction. , 1991, The American review of respiratory disease.

[116]  D. Clemmons,et al.  The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. , 1991, Chest.

[117]  N. Pride,et al.  A "splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis. , 1991, The European respiratory journal.

[118]  G. Patterson,et al.  Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group. , 1991, The Journal of thoracic and cardiovascular surgery.

[119]  R. Dittus,et al.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.

[120]  V. Kvetan,et al.  Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. , 1990, Archives of internal medicine.

[121]  T. Sensky,et al.  Patients' reactions to illness. , 1990, BMJ.

[122]  M. Becklake.  Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[123]  T. Thom.  International comparisons in COPD mortality. , 1989, The American review of respiratory disease.

[124]  O. Brändli,et al.  [Course and prognosis of chronic obstructive lung disease over 5 and 10 years]. , 1988, Schweizerische medizinische Wochenschrift.

[125]  D. Postma,et al.  Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? , 1988, The European respiratory journal.

[126]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[127]  N. Anthonisen,et al.  A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. , 1986, The New England journal of medicine.

[128]  D. Postma,et al.  Severe chronic airflow obstruction: can corticosteroids slow down progression? , 1985, European journal of respiratory diseases.

[129]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[130]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[131]  D. Smith,et al.  Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.

[132]  A. Cripps,et al.  Haemophilus influenzae oral vaccination against acute bronchitis. , 2000, The Cochrane database of systematic reviews.

[133]  M. Schluchter,et al.  Feasibility of a Clinical Trial of Augmentation Therapy for α1-Antitrypsin Deficiency , 2000 .

[134]  E. Wouters,et al.  Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[135]  G. Criner,et al.  Improvements in lung function, exercise, and quality of life in hypercapnic COPD patients after lung volume reduction surgery. , 1999, Chest.

[136]  J Zieliński,et al.  Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. , 1998, Chest.

[137]  J. Cooper,et al.  Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.

[138]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[139]  S. Rennard,et al.  Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs. , 1994, Chest.

[140]  B. Griffith,et al.  Lung transplantation: Report of the ATS workshop on lung transplantation , 1993 .